SCHEMBL7611831

SCHEMBL7611831

COCCO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)nc(F)nc21

nearest known ligand 0.71

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.71
▸ NT5E P21589 1/20 0.71
▸ HIF1A Q16665 1/20 0.71
▸ ADORA2A P29274 9/20 0.59
▸ ADORA2B P29275 8/20 0.59
▸ CA5A P35218 1/20 0.57
▸ ADORA3 P0DMS8 1/20 0.56
▸ ADORA1 P30542 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611839 1.00 LMNA (0.71) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL5506193 0.91 LMNA (0.68) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL3624008 0.90 ADORA2A (0.61) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL7608233 0.90 ADORA2A (0.61) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL7610042 0.90 LMNA (0.77) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL7610049 0.90 LMNA (0.77) LMNANT5EHIF1AADORA2AADORA2B
SCHEMBL1060588 0.85 ADORA1 (0.72) HIF1AADORA2AADORA2BADORA3ADORA1
SCHEMBL29408565 0.85 ADORA1 (0.72) HIF1AADORA2AADORA2BADORA3ADORA1
SCHEMBL28680450 0.85 ADORA1 (0.72) HIF1AADORA2AADORA2BADORA3ADORA1
SCHEMBL26370816 0.85 ADORA1 (0.72) HIF1AADORA2AADORA2BADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1198592-A4 OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES ISIS PHARMACEUTICALS INC (US) 2002-09-18 — — EP disclosed
EP-1198592-A1 OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES ISIS PHARMACEUTICALS, INC. (US) 2002-04-24 — — EP disclosed
US-6175004-B1 REACTING AN OLIGONUCLEOTIDE COMPRISING A HALOGENATED PURINE NUCLEOSIDE WITH AMINE; FOR STRONGER HYBRIDIZATION; DIAGNOSIS; GENETIC ENGINEERING; ANTISENSE AGENTS ISIS PHARMACEUTICALS, INC. 2001-01-16 — — US disclosed
WO-2001002608-A1 OLIGONUCLEOTIDES INCORPORATING BOTH 2-AMINOADENINE AND 5-SUBSTITUTED PYRIMIDINES ISIS PHARMACEUTICALS, INC. (US) 2001-01-11 — — WO disclosed
Send feedback